These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 32095915

  • 1. Blockade of NOP receptor modulates anxiety-related behaviors in mice exposed to inescapable stress.
    Silva AI, Holanda VAD, Azevedo Neto JG, Silva Junior ED, Soares-Rachetti VP, Calo G, Ruzza C, Gavioli EC.
    Psychopharmacology (Berl); 2020 Jun; 237(6):1633-1642. PubMed ID: 32095915
    [Abstract] [Full Text] [Related]

  • 2. Modulation of the NOP receptor signaling affects resilience to acute stress.
    Holanda VAD, Pacifico S, Azevedo Neto J, Finetti L, Lobão-Soares B, Calo G, Gavioli EC, Ruzza C.
    J Psychopharmacol; 2019 Dec; 33(12):1540-1549. PubMed ID: 31337258
    [Abstract] [Full Text] [Related]

  • 3. Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic-versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands.
    Asth L, Ruzza C, Malfacini D, Medeiros I, Guerrini R, Zaveri NT, Gavioli EC, Calo' G.
    Neuropharmacology; 2016 Jun; 105():434-442. PubMed ID: 26867504
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands.
    Gavioli EC, Calo' G.
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Feb; 372(5):319-30. PubMed ID: 16491387
    [Abstract] [Full Text] [Related]

  • 6. Nociceptin/orphanin FQ receptor agonists increase aggressiveness in the mouse resident-intruder test.
    Silva EF, Silva AI, Asth L, Souza LS, Zaveri NT, Guerrini R, Calo' G, Ruzza C, Gavioli EC.
    Behav Brain Res; 2019 Jan 01; 356():120-126. PubMed ID: 30142397
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM, Statnick MA, Rorick-Kehn LM, Pintar JE, Ansonoff M, Chen Y, Tucker RC, Ciccocioppo R.
    Pharmacol Ther; 2014 Mar 01; 141(3):283-99. PubMed ID: 24189487
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Blockade of nociceptin/orphanin FQ receptor signaling reverses LPS-induced depressive-like behavior in mice.
    Medeiros IU, Ruzza C, Asth L, Guerrini R, Romão PR, Gavioli EC, Calo G.
    Peptides; 2015 Oct 01; 72():95-103. PubMed ID: 26028163
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Activation of NOP receptor increases vulnerability to stress: role of glucocorticoids and CRF signaling.
    Holanda VAD, de Almeida RN, de Oliveira MC, da Silva Junior ED, Galvão-Coelho NL, Calo' G, Ruzza C, Gavioli EC.
    Psychopharmacology (Berl); 2024 May 01; 241(5):1001-1010. PubMed ID: 38270614
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/mu-opioid receptor agonists.
    Khroyan TV, Polgar WE, Jiang F, Zaveri NT, Toll L.
    J Pharmacol Exp Ther; 2009 Dec 01; 331(3):946-53. PubMed ID: 19713488
    [Abstract] [Full Text] [Related]

  • 17. The NOP antagonist BTRX-246040 increases stress resilience in mice without affecting adult neurogenesis in the hippocampus.
    D'Oliveira da Silva F, Azevedo Neto J, Sturaro C, Guarino A, Robert C, Gavioli EC, Calo G, Mouledous L, Ruzza C.
    Neuropharmacology; 2022 Jul 01; 212():109077. PubMed ID: 35513173
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder.
    Zhang Y, Simpson-Durand CD, Standifer KM.
    Br J Pharmacol; 2015 Jan 01; 172(2):571-82. PubMed ID: 24666365
    [Abstract] [Full Text] [Related]

  • 20. Nociceptin receptor antagonist SB 612111 decreases high fat diet binge eating.
    Hardaway JA, Jensen J, Kim M, Mazzone CM, Sugam JA, Diberto JF, Lowery-Gionta EG, Hwa LS, Pleil KE, Bulik CM, Kash TL.
    Behav Brain Res; 2016 Jul 01; 307():25-34. PubMed ID: 27036650
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.